Key result
In patients with acute aortic syndrome, elevated NT-proBNP was associated with cardiac involvement and served as an independent predictor of mortality.
Why the study?
Does the measurement of cardiac biomarkers predict mortality and cardiac involvement in patients with acute aortic syndrome?
Observational (n=260)
No
Does the measurement of cardiac biomarkers predict mortality and cardiac involvement in patients with acute aortic syndrome?
Elevated NT-proBNP is an independent predictor of mortality and is associated with cardiac involvement in patients with acute aortic syndrome, suggesting its utility in risk stratification.
Answers are grounded in this paper and cite their sources.
NT-proBNP was associated with cardiac involvement and mortality in AAS; leaves open its role in risk stratification pending prospective validation.
Objective: To investigate the usefulness of cardiac biomarkers in the evaluation of prognosis and cardiac involvement (CI) in patients with acute aortic syndrome (AAS). Methods: A total of 260 AAS patients with the measurements of cardiac biomarkers were divided into 2 groups; the survived (n=215, 60.6±13.7 years, 110 males) vs the dead (n=45, 64.5±13.6 years, 19 males). N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiac specific troponin-I (cTnI), C-reactive protein (CRP), creatinine kinase (CK), MB fraction of CK (CK-MB), and D-dimer were compared. Results: NT-proBNP and D-dimer were significantly elevated in the dead group than in the survived group (3558.7±5497.2 vs 949.9±2307.3 pg/mL, p<0.001, 4.5±5.1 vs 2.0±3.2 ug/mL, p<0.001, respectively). CI was observed in 59 patients (22.7%), and NT-proBNP was significantly elevated in patients with CI than in patients without CI (2497.7±4671.3 vs 722.5±1489.1 pg/mL, p=0.034). In univariate analysis, Stanford type A, CI, NT-proBNP, and D-dimer were significantly associated with mortality, but NT-proBNP was the only significant independent predictor of mortality in multivariate analysis. By receiver operating characteristic curve analysis, the optimal cut-off value to predict mortality was 517.0 pg/mL for NT-proBNP (area under the curve 0.797, sensitivity 86.7%, specificity 71.7%). Conclusion: The elevation of cardiac biomarkers is not infrequent in patients with AAS. NT-proBNP is significantly associated with CI and is an independent predictor of mortality in patients with AAS. The measurement of NT-proBNP would be useful in the risk stratification of AAS. (J Lipid Atheroscler 2016 June;5(1):27-36)
No takes yet. Share an insight, caveat, or question.
Kim et al. (2016) conducted an observational in Acute Aortic Syndrome (n=260). Elevated NT-proBNP vs. Lower NT-proBNP levels was evaluated on Mortality (OR 33.772, 95% CI 5.659-201.569, p=<0.001). In patients with acute aortic syndrome, elevated NT-proBNP was associated with cardiac involvement and served as an independent predictor of mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: